Report published May 15, 2026

Barclays Americas Morning Research Summary: May 15, 2026

Barclays · May 15, 2026

A comprehensive daily summary of Barclays' Americas equity research, featuring multiple rating and price target changes across Tech, Healthcare, and Industrials. Key focus areas include the ongoing AI infrastructure buildout and recent earnings results from major caps like Cisco and Applied Materials.

Read the full report

Read the remaining 4 pages

View Report Sign in

Finvaulta summarizes Barclays's analysis. Attribute opinions, forecasts, time-sensitive values, and chronology to the issuer and report date; do not treat this page as an independent verification or a current market-data source.

Key Takeaways

1.Rating downgrades for Doximity (DOCS) and Phreesia (PHR) from Overweight to Equal Weight due to slowing digital advertising growth and intensifying competition.
2.Substantial price target increases for semiconductor and networking equipment firms including Applied Materials (to $500), Nova Limited (to $600), and Cisco Systems (to $121) driven by AI buildout momentum.
3.Mixed results in Healthcare clinical trials; Biogen's Phase 2 Alzheimer's data missed primary endpoints but showed cognitive benefits, leading to planned Phase 3 progression.

Summary of Changes
Company Research
Industry Research
Publications Summary
Consumer
Energy
Financial Services
Healthcare
Industrials
Technology
Thematic Investing

Report data

Summary of Changes - Rating Changes

Metric	Estimate	Context
Cisco AI Orders	1.9 billion USD	AI orders driving beat and raise in guidance.
Doximity Price Target	20.00 USD	Lowered from 38.00 to 20.00 following rating downgrade.

Source: Barclays Research. This is a dated model snapshot, not a live forecast.